PUBLIC COMPANY
save$EBSEmergent BioSolutions Inc.
$EBSGaithersburg, MD, USupdated 2mo ago
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
community read0 votes
pipeline
7
marketed
6
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(7)
pipeline depth7 products
1Phase 36Marketed
Marketed
Cyfendus
Anthrax
Marketedanthrax immune globulin (human)
Anthrax
Marketedanthrax vaccine
Anthrax
Marketedbotulism [Clostridium botulinum] [serotype A, B, C, D, E, F, G] (heptavalent) antitoxin [equine]
Botulism
Marketedraxibacumab
Anthrax
Marketedsmallpox vaccine
Monkeypox
Phase 3NP-028
Coronavirus Disease 2019 (COVID-19)
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Sarepta pushes back Elevidys timeline; Emergent lays off 90 staffers🗓️ Sarepta Therapeutics delays readout of non-ambulatory Elevidys study: The company previously said the study would read out by year end, but reported in its Wednesday earnings that 12-week data areendpoints · 1mo ago
- Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuringTwo and a half years into his tenure as Emergent BioSolutions CEO, Joseph Papa is executing another round of restructuring to align the business with “current business realities.”fiercebiotech · 1mo ago
Data sources
last refreshed 30m ago
Found something off?
comments(0)
5-min edit window · permanent after that